# Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection

> **NCT03382548** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 460 (actual)

## Conditions studied

- Ventilator Associated Pneumonia
- Pneumonia, Bacterial

## Interventions

- **DRUG:** Reducing Antibiotics treatment duration
- **DRUG:** Standard Antibiotics treatment duration

## Key facts

- **NCT ID:** NCT03382548
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2023-01-23
- **Final completion:** 2023-03-22
- **Target enrollment:** 460 (ACTUAL)
- **Last updated:** 2024-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03382548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03382548, "Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03382548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*